DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

VALERIAN

Search structure
Synonyms:
4M98M04Z3Z
7D1DL7VY9S
Chinese valerian
Chinese valerian whole
Common valerian whole
FEMA NO. 3099
FMM0HE453U
Garden heliotrope whole
Garden valerian whole
Indian valerian whole
Japanese valerian whole
Mexican valerian whole
Pacific valerian whole
Powdered valerian extract
Sugandhabala whole
Tagara whole
Valerian
Valeriana officinalis
Valeriana officinalis extract
Valeriana officinalis rhizome dry extract
Valeriana officinalis root
Valeriana officinalis root extract
Valeriana officinalis root tincture
Valeriana officinalis root with rhizome
Valeriana officinalis whole
Valeriana pseudofficinalis whole
Valerian whole
Status: Phase 3
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: JWF5YAW3QW

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Anxiety 3 D001007 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108165
FDA SRS JWF5YAW3QW
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70